Compile Data Set for Download or QSAR
Found 450 Enz. Inhib. hit(s) with Target = 'Interleukin-1 beta'
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM86694(N'-(3-Chloro-4-morpholinophenyl)-N-hydroxyform...)copy SMILEScopy InChI
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MW2FQQPubMed
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531296(US11208399, Example 53)copy SMILES
Affinity DataIC50: 0.400nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531223((R)-2-(4-Methyl-6-((1-methylpiperidin-3-yl)amino)p...)copy SMILES
Affinity DataIC50: 0.400nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM65497(CC-220 (Compound 6) | US9694015, 6.4S)copy SMILEScopy InChI
Affinity DataIC50: 0.460nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a ⿿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531253(US11208399, Example 12)copy SMILES
Affinity DataIC50: 0.600nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531331(US11208399, Example 82)copy SMILES
Affinity DataIC50: 0.700nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531332(US11208399, Example 83a)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531288(US11208399, Example 47)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531289(US11208399, Example 48)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531319(US11208399, Example 71)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531220((R)-2-(6-((1-Ethylpiperidin-3-yl)amino)pyridazin-3...)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM77001(3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoin...)copy SMILEScopy InChI
Affinity DataIC50: 0.850nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a ⿿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531230(US11208399, Example 6)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531254(US11208399, Example 13)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531252(US11208399, Example 11)copy SMILES
Affinity DataIC50: 1.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531337(3-Methyl-2-(6-(((1R,2R,5R)-8-methyl-8-azabicyclo[3...)copy SMILES
Affinity DataIC50: 1.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531291(US11208399, Example 49)copy SMILES
Affinity DataIC50: 1.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531354(2-(6-(((3S, 5S)-5-Fluoro-1-methylpiperidin-3-yl)am...)copy SMILES
Affinity DataIC50: 1.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531339(2-(6-(((1S,2S,5S)-8-(2-Hydroxyethyl)-8-azabicyclo[...)copy SMILES
Affinity DataIC50: 1.80nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531364((R)-2-(6-((1-Ethylpiperidin-3-yl)amino)-5-methylpy...)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531232(US11208399, Example 7)copy SMILES
Affinity DataIC50: 1.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531292(US11208399, Example 50)copy SMILES
Affinity DataIC50: 2.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531323(US11208399, Example 74)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531293(US11208399, Example 51)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531282(US11208399, Example 41)copy SMILES
Affinity DataIC50: 3nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531224((R)-3-Methyl-2-(5-methyl-6-((1-methylpiperidin-3-y...)copy SMILES
Affinity DataIC50: 3nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531286(US11208399, Example 45)copy SMILES
Affinity DataIC50: 3.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531279(US11208399, Example 39)copy SMILES
Affinity DataIC50: 3.20nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531350(2-(6-(((R)-1-((S)-2-Hydroxypropyl)piperidin-3-yl)a...)copy SMILES
Affinity DataIC50: 3.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531318(US11208399, Example 70)copy SMILES
Affinity DataIC50: 3.5nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531351(2-(6-(((R)-1-((R)-2-Hydroxypropyl)piperidin-3-yl)a...)copy SMILES
Affinity DataIC50: 3.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531329(US11208399, Example 80)copy SMILES
Affinity DataIC50: 4.70nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531310(US11208399, Example 64)copy SMILES
Affinity DataIC50: 5.90nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531363((R)-3-Methyl-2-(5-methyl-6-(piperidin-3-ylamino)py...)copy SMILES
Affinity DataIC50: 6nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM77015((R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoi...)copy SMILEScopy InChI
Affinity DataIC50: 6.20nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a ⿿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531340(2-(6-(((3R,6R)-6-(Hydroxymethyl)-1-methylpiperidin...)copy SMILES
Affinity DataIC50: 6.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531352(2-(6-(((3S,5S)-5-Fluoropiperidin-3-yl)amino)pyrida...)copy SMILES
Affinity DataIC50: 6.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531280(US11208399, Example 40)copy SMILES
Affinity DataIC50: 6.80nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531311(US11208399, Example 65)copy SMILES
Affinity DataIC50: 7.40nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531360((3S,5R)-5-((6-(2-Hydroxy-6-methyl-4-(trifluorometh...)copy SMILES
Affinity DataIC50: 7.60nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM531302(US11208399, Example 56)copy SMILES
Affinity DataIC50: 8.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2JD50Z5US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398233(4-chloro-N-((4,4-difluorocyclohexyl)methyl)-1-(pip...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2HD7ZQ2US Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398220(4-chloro-N-((4,4-difluorocyclohexyl)methyl)-1-((1-...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398233(4-chloro-N-((4,4-difluorocyclohexyl)methyl)-1-(pip...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398219(4-chloro-N-((3,3-difluoro-5-methylcyclohexyl)methy...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398218(4-chloro-N-((3,3-difluorocyclohexyl)methyl)-1-(pyr...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398217(4-chloro-N-((3, 3-difluoro-1-hydroxycyclohexyl)met...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398117(4-chloro-1-(oxetan-3-yl)-N-((1-(4-phenylpiperazin-...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM398106(Preparations of 4-chloro-N-((4,4-difluorocyclohexy...)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26M395SUS Patent
TargetInterleukin-1 beta(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by PDSP Ki Database
LigandPNGBDBM450448(US10676433, Compound 158 | US10676433, Compound 76)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2HD7ZQ2US Patent
Displayed 1 to 50 (of 450 total ) | Next | Last >>
Jump to: